Sage Mountain Advisors LLC Bristol Myers Squibb CO Transaction History

Sage Mountain Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $238,652 - $270,585	4,974 New	4,974 $269,000
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $40,580 - $45,375	-701 Reduced 10.62%	5,897 $342,000
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $67,596 - $75,055	1,061 Added 19.16%	6,598 $421,000
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $129,580 - $146,973	1,972 Added 55.32%	5,537 $383,000
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $244,131 - $289,085	3,565 New	3,565 $256,000
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $50,398 - $55,506	-694 Reduced 15.87%	3,678 $283,000
Q1 2022 Aug 25, 2022	SELL	$61.48 - $73.72 $51,397 - $61,629	-836 Reduced 16.05%	4,372 $319,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $16,292 - $19,535	-265 Reduced 4.84%	5,208 $380,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $71,703 - $83,589	-1,337 Reduced 19.63%	5,473 $341,000
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $118 - $138	-2 Reduced 0.03%	6,810 $403,000
Q2 2021 Jul 22, 2021	BUY	$61.91 - $67.42 $421,730 - $459,265	6,812 New	6,812 $455,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Sage Mountain Advisors LLC with notifications on news.